Pineoblastoma: Clinical Trials

4 trials for Pineoblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Pineoblastoma: new trials by email Literature Review of Pineoblastoma trials Research Report on Pineoblastoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
EGFR806-specific chimeric antigen receptor (CAR) T cell - Central Nervous System Tumor, Pediatric, Glioma
Phase 1CompletedSeattle Children's Hospital112019-03-192025-12-17
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Gemcitabine, ribociclib, sonidegib - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedSt. Jude Children's Research Hospital682018-03-052024-05-31
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Adavosertib, Irinotecan Hydrochloride - Central Nervous System Embryonal Tumor With Rhabdoid Features, Central Nervous System Embryonal Tumor, Not Otherwise Specified
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)762014-03-282023-09-26
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
3-Dimensional Conformal Radiation Therapy, Carboplatin, Cisplatin - Medulloblastoma, Pineoblastoma
Phase 1CompletedNational Cancer Institute (NCI)332009-02-252022-01-13

Narrower conditions

Medulloblastoma (4)  ·  Pinealoma (4)  ·  Central Nervous System Neoplasms (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Brain Neoplasms (2)  ·  Choroid Plexus Carcinoma (2)  ·  Ependymoma (2)  ·  Glioma (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Rhabdoid Tumor (2)  ·  Astrocytoma (1)  ·  Glioblastoma (1)  ·  Lymphoma, Follicular (1)  ·  Meningioma (1)  ·  Microphthalmia, Isolated, with Coloboma 5 (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neuroectodermal Tumors (4)  ·  Neoplasms (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Brain Neoplasms (2)  ·  Glioma (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Germ Cell and Embryonal (2)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Automobiles (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Gemcitabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Irinotecan (1)  ·  Isotretinoin (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Platinum (1)  ·  Radiotherapy, Conformal (1)  ·  Thiotepa (1)  ·  Vincristine (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Seattle Children's Hospital (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Giles W. Robinson, MD (1)  ·  Juliane Gust, MD, PhD (1)  ·  Kristina A Cole (1)  ·  Sarah E Leary (1)

NIH funding

U01CA081457 (1), UM1CA081457 (1), UM1CA097452 (1)